Sotiris Vandoros

Cited by

	All	Since 2020
Citations	2148	1030
h-index	26	19
i10-index	42	30

240

120

180

20102011201220132014201520162017201820192020202120222023202420257 18 41 88 126 149 159 149 153 183 174 208 221 213 197 7

Public access

View all

6 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Panos KanavosAssociate Professor in International Health PolicyVerified email at lse.ac.uk
kawachi iHarvardVerified email at hsph.harvard.edu
Mauricio AvendanoUniversity of Lausanne -UnisanteVerified email at unil.ch
Tom StargardtProfessor for Health Care ManagementVerified email at uni-hamburg.de
Philipp HesselUnited Nations Economic Commission for EuropeVerified email at uniandes.edu.co
Alina VeliasLondon School of EconomicsVerified email at lse.ac.uk
Elena NicodResearch Officer, London School of Economics and Political ScienceVerified email at lse.ac.uk
Georgios KavetsosQueen Mary University of London | London School of EconomicsVerified email at lse.ac.uk
Alessandra FerrarioHarvard Medical School and Harvard Pilgrim Health Care InstituteVerified email at harvardpilgrim.org
Mireia Jofre-BonetOffice of Health Economics & City, University of LondonVerified email at ohe.org
Victoria Serra-SastreDepartment of Economics, City, Unviersity of LondonVerified email at city.ac.uk
Huseyin NaciLondon School of EconomicsVerified email at lse.ac.uk
Jonathan CylusVerified email at lse.ac.uk
Prof. Paul DolanLondon School of Economics and Political ScienceVerified email at lse.ac.uk
Caroline RudisillVerified email at sc.edu
Peter van der WindtAssociate Professor of Political Science, New York University - Abu DhabiVerified email at nyu.edu
Chris MurisDepartment of Economics, McMaster UniversityVerified email at mcmaster.ca
Pedro RaposoAssociate Professor of Econometrics, Universidade Catolica Portuguesa,Catolica Lisbon SBEVerified email at ucp.pt
Haruka GotoUCLVerified email at ucl.ac.uk
Katharina E BlankartBern University of Applied SciencesVerified email at bfh.ch

Sotiris Vandoros

UCL and Harvard University

Verified email at ucl.ac.uk - Homepage

Health Economics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Have health trends worsened in Greece as a result of the financial crisis? A quasi-experimental approach S Vandoros, P Hessel, T Leone, M Avendano The European Journal of Public Health 23 (5), 727-731, 2013	213	2013
Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales S Vandoros Social Science & Medicine 258, 113101, 2020	154	2020
Reforms in the Greek pharmaceutical market during the financial crisis S Vandoros, T Stargardt Health policy 109 (1), 1-6, 2013	153	2013
Differences in costs of and access to pharmaceutical products in the EU P Kanavos, S Vandoros, R Irwin, E Nicod, M Casson < bound method Organization. get_name_with_acronym of< Organization …, 2011	127	2011
Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs P Kanavos, A Ferrario, S Vandoros, GF Anderson Health affairs 32 (4), 753-761, 2013	125	2013
The association between economic uncertainty and suicide in the short-run S Vandoros, M Avendano, I Kawachi Social Science & Medicine 220, 403-410, 2019	107	2019
Determinants of branded prescription medicine prices in OECD countries PG Kanavos, S Vandoros Health economics, policy and law 6 (3), 337-367, 2011	94	2011
Tender systems for outpatient pharmaceuticals in the European Union: Evidence from the Netherlands, Germany and Belgium P Kanavos, L Seeley, S Vandoros LSE Health London School of Economics, 2009	85	2009
The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England M Jofre-Bonet, V Serra-Sastre, S Vandoros Social Science & Medicine 197, 213-225, 2018	79	2018
The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors F Von der Schulenburg, S Vandoros, P Kanavos Health economics review 1, 1-8, 2011	70	2011
The generics paradox revisited: empirical evidence from regulated markets S Vandoros, P Kanavos Applied Economics 45 (22), 3230-3239, 2013	61	2013
The differential impact of the financial crisis on health in Ireland and Greece: a quasi-experimental approach P Hessel, S Vandoros, M Avendano Public health 128 (10), 911-919, 2014	59	2014
The impact of bank competition and concentration on industrial growth G Liu, A Mirzaei, S Vandoros Economics Letters 124 (1), 60-63, 2014	51	2014
Competition in prescription drug markets: is parallel trade the answer? P Kanavos, S Vandoros Managerial and decision economics 31 (5), 325-338, 2010	42	2010
Raising the bar for market authorisation of new drugs H Naci, J Cylus, S Vandoros, A Sato, K Perampaladas Bmj 345, 2012	39	2012
Household expenditures for medicines and the role of free medicines in the Brazilian public health system AD Bertoldi, AJD Barros, AL Camargo, PC Hallal, S Vandoros, A Wagner, ... American journal of public health 101 (5), 916-921, 2011	39	2011
Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP P Kanavos, S Vandoros, P Garcia-Gonzalez Globalization and health 5, 1-13, 2009	37	2009
Economic uncertainty and suicide in the United States S Vandoros, I Kawachi European journal of epidemiology 36 (6), 641-647, 2021	35	2021
Greasy roads: the impact of bad financial news on road traffic accidents S Vandoros, G Kavetsos, P Dolan Risk analysis 34 (3), 556-566, 2014	35	2014
COVID-19, lockdowns and motor vehicle collisions: empirical evidence from Greece S Vandoros Injury prevention 28 (1), 81-85, 2022	34	2022

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors